Comparing Blood Tests for Sepsis in Burn ICU Patients
Part of Infections, Injuries & trauma clinical trials.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be admitted to the burn intensive care unit within 24 hours of the burn.
- The burn should cover 25% to 50% of your total body surface area (ask your doctor if you're unsure).
- You must have second- or third-degree burns (not just first-degree/sunburn-like).
- You must be otherwise healthy (no autoimmune diseases, no cancer, and classified as ASA 1 or 2 by your medical team).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This study tracks blood markers of infection in severely burned patients in the ICU. The goal is to see if these markers can help doctors detect sepsis earlier and guide treatment.
This study is testing two different simple blood tests to see which one better predicts sepsis (a severe infection response) and outcomes in ICU patients after surgery or trauma. It aims to help doctors identify high-risk patients sooner and improve care.
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Hear when a new Burns trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.